CN101450203A - Oral liquid for treating hemiplegia - Google Patents

Oral liquid for treating hemiplegia Download PDF

Info

Publication number
CN101450203A
CN101450203A CNA2007101956455A CN200710195645A CN101450203A CN 101450203 A CN101450203 A CN 101450203A CN A2007101956455 A CNA2007101956455 A CN A2007101956455A CN 200710195645 A CN200710195645 A CN 200710195645A CN 101450203 A CN101450203 A CN 101450203A
Authority
CN
China
Prior art keywords
radix
rhizoma
oral liquid
zingiberis recens
hemiplegia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101956455A
Other languages
Chinese (zh)
Inventor
吴彦勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2007101956455A priority Critical patent/CN101450203A/en
Publication of CN101450203A publication Critical patent/CN101450203A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an oral liquid for treating hemiplegia which is prepared from components by weight percentage including 1.4-1.9% ginseng, 2.4-2.9% atractylodes, 1.4-1.9% poria, 1.8-2.3% angelica, 1.8-2.3% chuanxiong, 1.4-1.9 white peony root, 1.4-1.9% rehmanniae radix, 1.4-1.9% rehmanniae vaporata, 1.4-1.9% rhizoma arisaematis, 1.4-1.9% rhizoma pinelliae, 1.4-1.9% dried old orange peel, 0.6-1.1% notopterygium root, 0.6-1.1% radix sileris, 1.4-1.9% rhizoma gastrodiae, 1.0-1.5% radix cyathulae, 0.4-0.9% safflower, 0.6-1.1 cassia twig, 1.0-1.5% scutellaria, 0.4-0.9% phellodendron, 1.0-1.5% jujube kernel, 0.4-0.9% combined spicebush, 0.4-0.9% glycyrrhiza, 35.6-36.1% bamboo juice and 35.6-36.1% ginger juice. The oral liquid has characteristics of rapid effect, better culative effect, high curative ratio and patient self-care for treating cerebrovascular disease sequela, facial paralysis, slurred speech and giddy by oral method.

Description

A kind of oral liquid for the treatment of hemiplegia
Technical field
The invention belongs to the Chinese drug preparation technique field, relate to a kind of Chinese medicine composition, be specifically related to a kind of oral liquid for the treatment of hemiplegia.
Background technology
Apoplexy is a kind of commonly encountered diseases that generally takes place in the present society, is the difficult problem of motherland's medical circle, especially sequal of cerebrovascular diseases: hemiplegia.Unsatisfactory curative effect.The treatment way that does not have success.
Summary of the invention
The purpose of this invention is to provide a kind of oral liquid for the treatment of hemiplegia, adopt the oral means of traditional medicine decoction, be used for the treatment of sequal of cerebrovascular diseases, hemiplegia, facial hemiparalysis, slurred speech, the vertigo, have basic treatment, the five internal organs are taken into account, the collateral dredging that stimulates the menstrual flow reaches the effect that patient's rehabilitation is taken care of oneself.
The technical solution adopted in the present invention is, a kind of oral liquid for the treatment of hemiplegia, composed of the following components by mass percentage: Radix Ginseng 1.4-1.9%, Rhizoma Atractylodis Macrocephalae 2.4-2.9%, Poria 1.4-1.9%, Radix Angelicae Sinensis 1.8-2.3%, Rhizoma Chuanxiong 1.8-2.3%, Radix Paeoniae Alba 1.4-1.9%, Radix Rehmanniae 1.4-1.9%, Radix Rehmanniae Preparata 1.4-1.9%, Rhizoma Arisaematis 1.4-1.9%, Rhizoma Pinelliae 1.4-1.9%, Pericarpium Citri Reticulatae 1.4-1.9%, Rhizoma Et Radix Notopterygii 0.6-1.1%, Radix Saposhnikoviae 0.6-1.1%, Rhizoma Gastrodiae 1.4-1.9%, Radix Cyathulae 1.0-1.5%, Flos Carthami 0.4-0.9%, Ramulus Cinnamomi 0.6-1.1%, Radix Scutellariae 1.0-1.5%, Cortex Phellodendri 0.4-0.9%, Semen Ziziphi Spinosae 1.0-1.5%, Radix Linderae 0.4-0.9%, Radix Glycyrrhizae 0.4-0.9%, fresh Succus Bambusae 35.6-36.1%, Rhizoma Zingiberis Recens juice 35.6-36.1%, above components contents summation is 100%.
Another technical scheme of the present invention is, the preparation method of above-mentioned Chinese medicine composition is got respectively: the Radix Ginseng of 1.4-1.9% by mass percentage, the Rhizoma Atractylodis Macrocephalae of 2.4-2.9%, the Poria of 1.4-1.9%, the Radix Angelicae Sinensis of 1.8-2.3%, the Rhizoma Chuanxiong of 1.8-2.3%, the Radix Paeoniae Alba of 1.4-1.9%, the Radix Rehmanniae of 1.4-1.9%, the Radix Rehmanniae Preparata of 1.4-1.9%, the Rhizoma Arisaematis of 1.4-1.9%, the Rhizoma Pinelliae of 1.4-1.9%, the Pericarpium Citri Reticulatae of 1.4-1.9%, the Rhizoma Et Radix Notopterygii of 0.6-1.1%, the Radix Saposhnikoviae of 0.6-1.1%, the Rhizoma Gastrodiae of 1.4-1.9%, the Radix Cyathulae of 1.0-1.5%, the Flos Carthami of 0.4-0.9%, the Ramulus Cinnamomi of 0.6-1.1%, the Radix Scutellariae of 1.0-1.5%, the Cortex Phellodendri of 0.4-0.9%, the Semen Ziziphi Spinosae of 1.0-1.5%, the Radix Linderae of 0.4-0.9%, the Radix Glycyrrhizae of 0.4-0.9%, the fresh Succus Bambusae of 35.6-36.1%, the Rhizoma Zingiberis Recens juice of 35.6-36.1%.Said components removed prodrug is added water except fresh Succus Bambusae and the Rhizoma Zingiberis Recens juice, connect and fry in shallow oil twice,, add Rhizoma Zingiberis Recens juice and fresh Succus Bambusae again medicine juice unification place.
Chinese medicine composition of the present invention can the meridian dredging, dispel the wind, eliminate the phlegm, blood stasis dispelling blood, damp eliminating heat, fill blood, strengthening the spleen and stomach, accent the five internal organs, and reach the purpose of curing hemiplegia.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
A kind of oral liquid for the treatment of hemiplegia of the present invention, composed of the following components by mass percentage: Radix Ginseng 1.4-1.9%, Rhizoma Atractylodis Macrocephalae 2.4-2.9%, Poria 1.4-1.9%, Radix Angelicae Sinensis 1.8-2.3%, Rhizoma Chuanxiong 1.8-2.3%, Radix Paeoniae Alba 1.4-1.9%, Radix Rehmanniae 1.4-1.9%, Radix Rehmanniae Preparata 1.4-1.9%, Rhizoma Arisaematis 1.4-1.9%, Rhizoma Pinelliae 1.4-1.9%, Pericarpium Citri Reticulatae 1.4-1.9%, Rhizoma Et Radix Notopterygii 0.6-1.1%, Radix Saposhnikoviae 0.6-1.1%, Rhizoma Gastrodiae 1.4-1.9%, Radix Cyathulae 1.0-1.5%, Flos Carthami 0.4-0.9%, Ramulus Cinnamomi 0.6-1.1%, Radix Scutellariae 1.0-1.5%, Cortex Phellodendri 0.4-0.9%, Semen Ziziphi Spinosae 1.0-1.5%, Radix Linderae 0.4-0.9%, Radix Glycyrrhizae 0.4-0.9%, fresh Succus Bambusae 35.6-36.1%, Rhizoma Zingiberis Recens juice 35.6-36.1%, above components contents summation is 100%.Said components is removed except fresh Succus Bambusae and the Rhizoma Zingiberis Recens juice.Prodrug is added water connect and to fry in shallow oil twice, after medicine juice unification place, add fresh Succus Bambusae again and Rhizoma Zingiberis Recens juice is made oral liquid, each oral 50 milliliters.
Shang Chen village, bent villages and small towns, Quwo County is burnt beautiful gloomy, suffers from cerebral thrombosis, left hemiplegia, and it is uneven that the trouble foot is put ground, suffers from hands and can touch chin, and finger can not be grabbed thing, a year and a half.Obey this oral liquid, recover normal after 36 days, be as good as with premorbid.
Bent villages and small towns, the Quwo County village, Wenxi County village Jin people's commune suffers from cerebral hemorrhage left side half body and satisfies, and lower limb can be walked reluctantly, suffers from arm and can lift to the tip of the nose place, suffers from hands and can not move 11 months, obeys this oral liquid, and finger can be moving in 10 days, and life in 30 days is taken care of oneself fully.

Claims (2)

1. oral liquid for the treatment of hemiplegia, it is characterized in that, composed of the following components by mass percentage: Radix Ginseng 1.4-1.9%, Rhizoma Atractylodis Macrocephalae 2.4-2.9%, Poria 1.4-1.9%, Radix Angelicae Sinensis 1.8-2.3%, Rhizoma Chuanxiong 1.8-2.3%, Radix Paeoniae Alba 1.4-1.9%, Radix Rehmanniae 1.4-1.9%, Radix Rehmanniae Preparata 1.4-1.9%, Rhizoma Arisaematis 1.4-1.9%, Rhizoma Pinelliae 1.4-1.9%, Pericarpium Citri Reticulatae 1.4-1.9%, Rhizoma Et Radix Notopterygii 0.6-1.1%, Radix Saposhnikoviae 0.6-1.1%, Rhizoma Gastrodiae 1.4-1.9%, Radix Cyathulae 1.0-1.5%, Flos Carthami 0.4-0.9%, Ramulus Cinnamomi 0.6-1.1%, Radix Scutellariae 1.0-1.5%, Cortex Phellodendri 0.4-0.9%, Semen Ziziphi Spinosae 1.0-1.5%, Radix Linderae 0.4-0.9%, Radix Glycyrrhizae 0.4-0.9%, fresh Succus Bambusae 35.6-36.1%, Rhizoma Zingiberis Recens juice 35.6-36.1%, above components contents summation is 100%.
2. oral liquid for the treatment of hemiplegia, it is characterized in that, get the Radix Ginseng of 1.4-1.9% respectively by the quality proportioning, the Rhizoma Atractylodis Macrocephalae of 2.4-2.9%, the Poria of 1.4-1.9%, the Radix Angelicae Sinensis of 1.8-2.3%, the Rhizoma Chuanxiong of 1.8-2.3%, the Radix Paeoniae Alba of 1.4-1.9%, the Radix Rehmanniae of 1.4-1.9%, the Radix Rehmanniae Preparata of 1.4-1.9%, the Rhizoma Arisaematis of 1.4-1.9%, the Rhizoma Pinelliae of 1.4-1.9%, the Pericarpium Citri Reticulatae of 1.4-1.9%, the Rhizoma Et Radix Notopterygii of 0.6-1.1%, the Radix Saposhnikoviae of 0.6-1.1%, the Rhizoma Gastrodiae of 1.4-1.9%, the Radix Cyathulae of 1.0-1.5%, the Flos Carthami of 0.4-0.9%, the Ramulus Cinnamomi of 0.6-1.1%, the Radix Scutellariae of 1.0-1.5%, the Cortex Phellodendri of 0.4-0.9%, the Semen Ziziphi Spinosae of 1.0-1.5%, the Radix Linderae of 0.4-0.9%, the Radix Glycyrrhizae of 0.4-0.9%, the fresh Succus Bambusae of 35.6-36.1%, the Rhizoma Zingiberis Recens juice of 35.6-36.1%, said components is removed except fresh Succus Bambusae and the Rhizoma Zingiberis Recens juice, prodrug is added water, connect and fry in shallow oil twice, with medicine juice unification place, add Rhizoma Zingiberis Recens juice and fresh Succus Bambusae again.
CNA2007101956455A 2007-12-05 2007-12-05 Oral liquid for treating hemiplegia Pending CN101450203A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101956455A CN101450203A (en) 2007-12-05 2007-12-05 Oral liquid for treating hemiplegia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101956455A CN101450203A (en) 2007-12-05 2007-12-05 Oral liquid for treating hemiplegia

Publications (1)

Publication Number Publication Date
CN101450203A true CN101450203A (en) 2009-06-10

Family

ID=40732801

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101956455A Pending CN101450203A (en) 2007-12-05 2007-12-05 Oral liquid for treating hemiplegia

Country Status (1)

Country Link
CN (1) CN101450203A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656571A (en) * 2013-11-26 2014-03-26 韩必芝 Sargentgloryvine stem cassia twig electuary and preparation method thereof
CN104208643A (en) * 2014-09-25 2014-12-17 刘建忠 Chinese medicine for treating hemiplegia and preparation method thereof
CN104645189A (en) * 2015-03-05 2015-05-27 于巧媛 Traditional Chinese medicine composition for treating phlegm stagnation type cerebral arteriosclerosis
CN105687791A (en) * 2016-03-11 2016-06-22 姜汝明 Hemiplegia Kangfuling

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103656571A (en) * 2013-11-26 2014-03-26 韩必芝 Sargentgloryvine stem cassia twig electuary and preparation method thereof
CN104208643A (en) * 2014-09-25 2014-12-17 刘建忠 Chinese medicine for treating hemiplegia and preparation method thereof
CN104645189A (en) * 2015-03-05 2015-05-27 于巧媛 Traditional Chinese medicine composition for treating phlegm stagnation type cerebral arteriosclerosis
CN105687791A (en) * 2016-03-11 2016-06-22 姜汝明 Hemiplegia Kangfuling

Similar Documents

Publication Publication Date Title
CN102430079B (en) Traditional Chinese medicine composite for treating stranguria
CN101028481A (en) Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion
CN101134085A (en) Traditional Chinese medicine for treating apoplectic hemiplegia
CN103463586A (en) Traditional Chinese medicine composition for treating restless legs syndrome
CN104043087A (en) Traditional Chinese medicine composition for treating Raynaud syndrome
CN101450203A (en) Oral liquid for treating hemiplegia
CN101518640A (en) Chinese traditional medicine prescription for treating tumor
CN1181849C (en) Gastropathy treating Chinese medicine
CN101129970A (en) Traditional Chinese medicine for treating middle and late stage liver cancer
CN1186687A (en) Cancer preventing curing medicine series and its preparation
CN101167932A (en) Traditional Chinese medicine for treating chronic hepatitis B
CN101612283A (en) Method for treating cow infertility by using traditional Chinese medicine
CN102406765B (en) Traditional Chinese medicine composition for treating acne
CN101129893A (en) Traditional Chinese medicine for treating cervical spondylosis with diarrhea
CN101134099A (en) Traditional Chinese medicine for treating vertigo caused by vertebrobasilar artery insufficiency
CN104147526A (en) Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof
CN1686227A (en) Menstruation regulating powder
CN103083632B (en) Traditional Chinese medicine for treating recurrent aphthae
CN1263479C (en) Chinese traditional medicine for treating cardiopathy
CN105362682A (en) External-use medicine for treating hypomenorrhea
CN103784720A (en) Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose
CN103157006A (en) Oral traditional Chinese medicine formula for treating osteoarthritis
CN1309412C (en) Medicine composition for treating AIDS and preparing method thereof
CN102846892A (en) Acute icterus type infectious hepatitis treatment decoction
CN102058812A (en) Traditional Chinese medicine for treating swine dyspepsia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090610